Market Outlook

By 2035, the U.S. Infusion Pumps Market is expected to reach approximately USD 14.76 billion, expanding at a CAGR of 8.25% during the forecast period 2026–2035. The market was valued at approximately USD 6.68 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. infusion pumps industry represents a clinically essential component of medication delivery infrastructure across hospitals, ambulatory infusion centers, oncology clinics, specialty pharmacies, home healthcare programs, long-term care facilities, and diabetes management settings. Infusion pumps are used to deliver medications, fluids, nutrients, insulin, blood products, analgesics, antibiotics, chemotherapy, immunoglobulins, and other therapies at controlled rates. Their strategic importance is increasing as the American healthcare system manages larger volumes of high-acuity patients, complex biologic therapies, chronic diseases, and care delivered outside conventional inpatient environments.

The market expanded from approximately USD 4.58 billion in 2021 to USD 6.06 billion in 2024. Historical growth was supported by post-pandemic normalization of hospital procedures, recovery in oncology infusion volumes, renewed hospital investment in smart pump fleets, expansion of automated insulin delivery, and rising use of ambulatory pumps for home-based treatment. In 2025, market value reached an estimated USD 6.68 billion as health systems accelerated replacement of aging large-volume pumps, implemented electronic medical record connectivity, expanded dose-error reduction systems, and invested in devices designed to support lower nursing workload.

The market sizing includes infusion pump hardware, pump-specific administration sets and proprietary disposables, connectivity and safety software, maintenance services, and recurring consumables directly associated with pump platforms. Generic intravenous fluids, non-pump gravity administration products, standalone vascular access devices, and unrelated drug-delivery supplies are excluded. This scope reflects the commercial value captured by infusion pump manufacturers and their integrated medication-delivery ecosystems rather than the entire intravenous therapy market.

The U.S. market is transitioning from standalone electromechanical pumps toward integrated infusion management platforms. Modern purchasing decisions increasingly consider interoperability, cybersecurity, drug-library governance, fleet utilization, alarm management, biomedical service requirements, medication safety, and the ability to document infusion activity directly within the patient record. Large integrated delivery networks are consequently evaluating infusion technology as enterprise infrastructure rather than as an isolated capital equipment category.

Growth through 2035 will be driven by three parallel replacement and adoption cycles. Hospitals will modernize large-volume, syringe, patient-controlled analgesia, and ambulatory pump fleets. Diabetes care will continue shifting toward connected and automated insulin delivery. Home infusion providers and specialty pharmacies will expand portable pump utilization as payers redirect appropriate therapies away from higher-cost hospital settings. These overlapping cycles give the U.S. infusion pumps market a balanced revenue profile across capital equipment, recurring disposables, software, services, and wearable devices.

 

Introduction

According to the U.S. Infusion Pumps Market Report, infusion pump demand is shaped by the scale of the American care-delivery system, the growing complexity of medication regimens, persistent medication-safety requirements, and the movement of infusion therapy across multiple sites of care. The United States has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and over 35.6 million annual hospital admissions. These institutions maintain extensive installed bases of large-volume pumps, syringe pumps, patient-controlled analgesia systems, enteral pumps, ambulatory pumps, and associated medication-management software.

Infusion pumps are embedded in almost every high-acuity hospital service line. Intensive care units depend on syringe and volumetric pumps for vasoactive drugs, sedation, antibiotics, insulin, anticoagulants, and electrolyte replacement. Oncology departments use ambulatory and volumetric systems for chemotherapy and supportive treatment. Operating rooms and post-anesthesia care units require pumps for anesthesia, analgesia, and fluid management. Neonatal and pediatric units need highly precise, low-flow delivery systems. Emergency departments rely on rapid deployment, standardized drug libraries, and flexible channel configurations.

The clinical demand pool is substantial. Approximately 40.1 million people in the United States are estimated to have diagnosed or undiagnosed diabetes, including about 2.1 million people with diagnosed type 1 diabetes. The expansion of automated insulin delivery into broader age groups and selected patients with insulin-requiring type 2 diabetes is increasing the addressable market for wearable and tubeless pumps. In oncology, more than 2 million new cancer cases were expected in the United States during 2025, supporting recurring demand for chemotherapy, immunotherapy, biologic treatment, hydration, pain management, and supportive infusions.

Infusion pumps also serve a growing population of patients receiving long-duration treatment for immune deficiencies, gastrointestinal disorders, neurological diseases, pulmonary hypertension, infectious diseases, chronic pain, and nutritional deficiencies. Many of these therapies can be administered through ambulatory or home infusion models when the patient is clinically stable. Medicare provides coverage pathways for certain infusion pumps, supplies, and qualifying home infusion services, although reimbursement depends on the device, drug, benefit category, site of care, and medical-necessity criteria.

The economic environment reinforces the importance of infusion workflow efficiency. U.S. healthcare spending reached approximately USD 5.3 trillion in 2024, while hospital expenditures rose to about USD 1.63 trillion. Hospitals face continuing pressure from labor costs, pharmaceutical expenses, claims denials, supply-chain disruption, and reimbursement constraints. Infusion systems that reduce manual programming, prevent avoidable medication errors, improve pump availability, automate documentation, and lower biomedical maintenance requirements can therefore create value beyond their purchase price.

Infusion procurement is typically multidisciplinary. Nursing leadership evaluates usability, alarm burden, and bedside workflow. Pharmacy teams assess drug libraries, dose-error reduction systems, compounding practices, and medication-standardization capabilities. Information technology and cybersecurity teams examine network architecture, authentication, patching, software support, and electronic medical record integration. Biomedical engineering evaluates reliability, serviceability, battery performance, fleet management, and total lifecycle cost. Value-analysis committees examine acquisition cost, disposable utilization, clinical evidence, training burden, supplier stability, and implementation risk.

From 2026 to 2035, the central competitive issue will be whether manufacturers can convert pumps into safer and more productive medication-delivery platforms. Suppliers that combine reliable hardware, intuitive interfaces, closed-loop documentation, analytics, centralized software deployment, secure connectivity, and dependable consumable supply will be better positioned than companies competing primarily on unit price.

 

Key Market Drivers: What’s Fueling the U.S. Infusion Pumps Market Boom?

The first major driver is the increasing intensity and complexity of hospital medication delivery. U.S. hospitals manage large volumes of continuous and intermittent infusions involving medications with narrow therapeutic ranges and serious consequences if delivered incorrectly. Critical care patients may require multiple simultaneous infusions, creating demand for modular systems, multi-channel configurations, accurate low-flow delivery, centralized monitoring, and standardized drug libraries. Growth in intensive care utilization, complex surgery, organ transplantation, neonatal care, and advanced cardiovascular treatment supports recurring pump demand.

A second driver is the replacement of aging hospital infusion pump fleets. Infusion systems are long-lived capital assets, but software obsolescence, cybersecurity expectations, battery degradation, service costs, recall history, and incompatibility with newer electronic medical records can accelerate replacement decisions. Many hospitals delayed capital purchases during periods of operational uncertainty and are now evaluating enterprise-wide modernization. These projects can involve thousands of pumps, extensive software configuration, clinical training, wireless infrastructure assessment, and multiyear service contracts.

A third driver is the increasing prioritization of medication safety. Manual programming creates opportunities for transcription mistakes, decimal errors, incorrect dose selection, wrong-rate programming, and failure to comply with standardized drug limits. Smart pumps equipped with dose-error reduction systems can compare programmed parameters with institution-specific medication libraries and generate soft or hard alerts. Bidirectional electronic medical record integration further reduces manual entry by allowing verified orders to populate the pump and completed infusion information to return to the patient record.

The economic value of interoperability is becoming more measurable. Analysis involving more than one million infusions at a U.S. academic health system indicated that electronic medical record integration was associated with lower frequencies of several infusion safety alerts and faster programming. The evidence supports a procurement shift from evaluating whether a pump is technically capable of connectivity to evaluating how reliably the connected workflow performs across nursing, pharmacy, information technology, and clinical operations.

A fourth driver is the scale of diabetes and the expansion of automated insulin delivery. Approximately 12% of the U.S. population has diabetes, and millions of patients require insulin. Traditional insulin pumps are increasingly being replaced or supplemented by systems connected to continuous glucose monitors and automated dosing algorithms. Tubeless patch pumps, compact durable pumps, smartphone-enabled controllers, and hybrid closed-loop systems are reducing the operational burden associated with intensive insulin therapy.

The commercial opportunity is expanding beyond the historically pump-intensive type 1 diabetes population. Regulatory clearance of automated insulin dosing for adults with type 2 diabetes has broadened the potential customer base. Adoption will depend on payer coverage, prescribing behavior, patient training, affordability, interoperability with glucose sensors, and demonstrated improvement in glucose control. Nevertheless, the shift gives diabetes-focused infusion pump companies access to a significantly larger long-term population.

A fifth driver is the sustained oncology treatment burden. More than 2 million new cancer diagnoses in a single year and a cancer-survivor population exceeding 18 million create recurring demand for chemotherapy, targeted therapies, immunotherapy, hydration, antiemetics, pain treatment, and supportive drugs. Infusion delivery occurs across hospital outpatient departments, physician-owned oncology practices, freestanding infusion centers, and patient homes. Portable pumps are particularly important for continuous chemotherapy protocols that allow patients to leave the facility while treatment continues.

A sixth driver is the migration of appropriate therapies to ambulatory and home settings. Commercial payers, Medicare programs, health systems, specialty pharmacies, and patients are increasingly interested in alternatives to hospital outpatient infusion when safety and reimbursement requirements can be met. Home infusion can reduce facility costs and travel burden while allowing patients to receive extended antibiotic therapy, parenteral nutrition, immune globulin, pain medication, and selected biologics in familiar environments.

This migration does not eliminate the need for clinical support. Instead, it shifts demand toward pumps that are portable, easy to program, resistant to misuse, remotely supportable, and suitable for patient or caregiver operation. Providers also require reliable delivery logistics, backup procedures, nursing support, patient education, monitoring, pharmacy coordination, and clear escalation protocols. Manufacturers that understand this broader home infusion workflow can create value beyond supplying the device.

A seventh driver is the growing commercial importance of specialty pharmaceuticals and biologics. Many newer therapies require subcutaneous or intravenous administration, weight-based dosing, controlled infusion rates, or extended administration periods. High drug costs increase the consequences of delivery failure, wastage, leakage, and interrupted therapy. Pumps capable of handling biologic viscosity, larger subcutaneous volumes, and accurate delivery may become increasingly important as pharmaceutical manufacturers develop therapies intended for decentralized care.

An eighth driver is hospital labor pressure. Nursing teams must manage medication verification, pump setup, line tracing, alarm response, documentation, drug-library compliance, and patient monitoring. A system that saves only a few seconds per infusion can produce meaningful enterprise-level productivity when applied across millions of annual programming events. Health systems are therefore examining the number of steps required to start an infusion, the clarity of the user interface, the frequency of non-actionable alarms, and the ease of locating and maintaining pumps.

A ninth driver is cybersecurity and regulatory scrutiny. Connected pumps interact with wireless networks, servers, clinical software, drug libraries, electronic records, and remote service systems. Every connection can improve workflow but also increase the attack surface. Procurement decisions increasingly require software bills of materials, vulnerability-management processes, authentication controls, patching commitments, encryption, secure deployment architecture, and defined support periods. Manufacturers unable to demonstrate mature lifecycle cybersecurity may face longer sales cycles or exclusion from enterprise contracts.

A tenth driver is supply-chain resilience. Infusion therapy depends on the availability of pumps, proprietary tubing, cassettes, syringes, batteries, repair components, intravenous solutions, and sterile disposables. Hospitals have become more sensitive to single-source dependency following shortages, manufacturing disruptions, natural disasters, and quality-related supply interruptions. Dual sourcing is not always practical because administration sets are frequently proprietary. Supplier manufacturing capacity, inventory visibility, domestic distribution, and continuity planning are therefore becoming material competitive differentiators.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. infusion pumps market is moving away from incremental hardware improvements toward enterprise medication-delivery systems. The next generation of competition will be defined by how effectively pumps interact with clinicians, medication orders, drug libraries, hospital networks, analytics platforms, and patient-monitoring systems.

Electronic medical record interoperability is one of the most important innovation areas. Auto-programming can transfer verified medication orders to the appropriate pump channel after patient, medication, and device identification. Auto-documentation can return infusion status, rate changes, volume infused, and completion data to the electronic record. When implemented correctly, this workflow reduces manual transcription and supports a more complete medication-administration record.

The value of interoperability depends on operational execution. A technically connected pump may still underperform if barcode scanning is inconsistent, wireless coverage is weak, drug libraries are poorly maintained, pump-channel association is confusing, or clinical staff bypass the workflow. Manufacturers are therefore expanding implementation services, network assessment, pharmacy configuration, training, optimization analytics, and post-deployment support. The winning platform will be the one that produces reliable adoption rather than simply offering a connectivity feature.

Precision at very low flow rates is another major innovation priority. Neonatal, pediatric, anesthesia, and critical care patients may receive potent medications in small volumes. Flow variability, startup delay, occlusion response, syringe characteristics, pump height, tubing compliance, and environmental conditions can influence delivery performance. New systems are being engineered to improve consistency under real-world conditions and provide more dependable documentation of what has actually reached the patient.

User-interface design is receiving greater attention because infusion programming occurs in high-pressure environments. Touchscreens, guided programming, standardized workflows, clear alarm prioritization, contextual safety feedback, and fewer unnecessary steps can reduce cognitive burden. Hospitals increasingly test pumps in simulated bedside scenarios before procurement, using nurses, pharmacists, anesthesiologists, biomedical engineers, and information technology specialists to identify workflow risks.

Centralized software management is also advancing. Health systems want to distribute drug-library updates, firmware, clinical profiles, and security patches across large pump fleets without physically touching every device. Cloud-enabled or centrally managed platforms can improve version control, reduce variation between facilities, and support faster response to safety issues. These capabilities are particularly valuable for multihospital systems with thousands of devices and geographically dispersed clinical operations.

Infusion analytics are emerging as a strategic layer. Pump data can be used to measure drug-library compliance, overridden alerts, programming patterns, alarm frequency, delayed infusions, fleet utilization, device location, battery health, and maintenance needs. Pharmacy and nursing leaders can use this information to refine medication limits, identify education gaps, and evaluate whether certain alerts produce meaningful intervention or unnecessary fatigue.

Wearable and tubeless insulin pumps represent another major area of innovation. Integration with continuous glucose monitoring and adaptive algorithms is moving diabetes management closer to automated physiological control. Competitive differentiation increasingly depends on time in range, ease of onboarding, size, wear duration, reservoir capacity, smartphone control, sensor compatibility, pediatric indications, type 2 diabetes eligibility, and payer access.

Portable ambulatory pumps are also evolving. Manufacturers are improving battery life, portability, drug-protocol flexibility, event logging, remote support, and protection against accidental programming. For home infusion providers, the device must be simple enough for patient use while retaining sufficient controls for complex therapy. Pumps that reduce training burden and simplify logistics can help providers expand safely without proportionate increases in clinical staff.

Disposable and elastomeric pumps remain relevant because they are lightweight, require no batteries, and can be convenient for selected antibiotic, analgesic, and chemotherapy protocols. Their limitations include reduced programmability, dependence on environmental conditions, limited connectivity, and less real-time monitoring. Innovation is focused on improving flow consistency, expanding drug compatibility, reducing material concerns, and matching devices more precisely to prescribed therapy duration.

On-body delivery systems are creating an adjacent growth frontier. These devices are designed to administer larger-volume subcutaneous biologics over a controlled period, potentially reducing dependence on intravenous infusion chairs. Their commercial success will depend on pharmaceutical-device partnerships, drug formulation, patient comfort, reliability, reimbursement, manufacturing scale, and the ability to support high-value therapies outside traditional facilities.

Cybersecurity-by-design is becoming part of product differentiation. Hospitals increasingly expect secure boot processes, encrypted communication, authentication, access controls, vulnerability monitoring, rapid patch deployment, network segmentation guidance, and support aligned with the device’s full useful life. Manufacturers that treat cybersecurity as a continuous service rather than a one-time regulatory requirement will be more credible enterprise partners.

Artificial intelligence is likely to have a supporting rather than autonomous role during the early forecast period. Potential applications include identifying unusual programming patterns, predicting device maintenance needs, prioritizing alarms, optimizing fleet allocation, and detecting deviations from expected infusion behavior. Adoption will depend on clinical validation, transparency, integration quality, liability considerations, and the ability to avoid creating additional alert burden.

 

Segmentation Insights

The U.S. Infusion Pumps Market is segmented on the basis of product type, application, technology and delivery modality, end user, and region.

 

By Product Type

Large-Volume and Volumetric Infusion Pumps

Large-volume and volumetric pumps form the core of the hospital infusion infrastructure and represented the largest institutional product category in 2025. These devices deliver intravenous fluids, medications, blood products, parenteral nutrition, and other therapies across medical-surgical units, critical care, emergency departments, operating rooms, oncology, and specialty care.

Demand is driven primarily by hospital fleet size, replacement cycles, electronic medical record integration, and recurring administration-set utilization. Large health systems generally prefer platforms that can be standardized across multiple hospitals and connected to centralized drug-library and analytics software. Because pumps and proprietary sets create a long-term commercial relationship, procurement decisions can influence manufacturer revenue for many years.

Growth will be supported by smart pump replacement, improved low-flow performance, multi-channel capability, interoperability, and centralized management. The segment will remain highly competitive because fleet conversion carries significant training, validation, and implementation costs. Once a health system has standardized on a platform, switching barriers can be substantial.

Insulin Pumps

Insulin pumps represent one of the largest and fastest-evolving product segments by value. The category includes durable tethered pumps, tubeless patch pumps, automated insulin delivery systems, disposable components, infusion sets, reservoirs, controllers, and associated software.

The segment benefits from approximately 2.1 million diagnosed type 1 diabetes patients and a much larger insulin-requiring type 2 diabetes population. Automated dosing, continuous glucose monitor integration, smartphone control, and reduced device burden are improving the clinical and consumer value proposition. Recurring pod, cartridge, reservoir, and infusion-set purchases create an attractive revenue model for manufacturers.

Growth through 2035 will depend on payer coverage, patient affordability, endocrinologist capacity, training resources, interoperability, and product reliability. Expansion into type 2 diabetes can significantly increase the addressable market, although adoption will be selective and influenced by insulin intensity, patient preference, technical comfort, and demonstrated economic value.

Ambulatory Infusion Pumps

Ambulatory pumps are used for chemotherapy, antibiotics, pain management, parenteral nutrition, pulmonary hypertension therapies, and other continuous or intermittent treatments. They are designed to support patient mobility and may be used in hospitals, outpatient centers, or homes.

This segment is expected to expand above the market average as treatment moves away from inpatient settings. Important purchasing criteria include portability, battery performance, programming flexibility, reservoir or cassette options, lockout functionality, alarm clarity, event history, remote support, and compatibility with pharmacy workflows.

Ambulatory pumps also enable providers to discharge patients sooner or avoid admission when clinically appropriate. Their economic value is therefore linked to total site-of-care savings rather than equipment price alone. Growth will be strongest among providers capable of coordinating pharmacy, nursing, patient education, remote monitoring, and emergency support.

Syringe Infusion Pumps

Syringe pumps are essential for precise delivery of low-volume, high-potency medications. They are heavily used in neonatal and pediatric intensive care, anesthesia, critical care, operating rooms, and research environments. Common applications include vasoactive drugs, sedatives, analgesics, insulin, anticoagulants, and medications requiring highly controlled rates.

Hospitals evaluate syringe pumps according to accuracy, startup performance, occlusion detection, compatible syringe brands and sizes, ease of loading, stackability, drug-library integration, and interoperability. Neonatal applications require particularly strong performance at low flow rates because small deviations can have meaningful clinical consequences.

The segment will grow through replacement demand, expansion of intensive care capacity, and integration into enterprise smart pump platforms. Manufacturers offering large-volume and syringe pumps through one software environment may gain an advantage in multihospital contracts.

Enteral, Implantable, Elastomeric, and Specialty Pumps

This category includes enteral feeding pumps, implantable infusion systems, elastomeric devices, and drug-specific specialty pumps. Enteral pumps support patients unable to meet nutritional needs orally and are used in hospitals, long-term care facilities, and homes. Medicare coverage pathways for qualifying enteral nutrition equipment support demand among eligible patients.

Implantable pumps are used in selected pain, spasticity, and oncology applications. Their market is smaller by unit volume but clinically specialized. Adoption depends on surgical implantation, refill infrastructure, patient selection, reimbursement, and long-term follow-up.

Elastomeric pumps are frequently used for ambulatory antibiotics, analgesia, and selected chemotherapy protocols. Their simple design and portability are attractive, but flow variability and lack of programmability limit their use in therapies requiring frequent adjustments or connected monitoring.

 

By Application

Diabetes Management

Diabetes management is the leading application by value because of the scale of the patient population and the recurring nature of pump consumables. Approximately 40.1 million Americans have diagnosed or undiagnosed diabetes, while more than 115 million adults are estimated to have prediabetes. Although only a portion of this population is suitable for pump therapy, the addressable base is large.

The strongest growth will come from automated insulin delivery, tubeless systems, broader type 2 diabetes adoption, improved sensor integration, and simplified onboarding. Competitive success will require not only strong technology but also payer contracting, pharmacy or durable medical equipment distribution, patient support, prescribing education, and dependable consumable supply.

Oncology and Hematology

Oncology is a major infusion pump application because chemotherapy, immunotherapy, supportive drugs, hydration, blood products, and pain management frequently require controlled administration. With more than 2 million new cancer diagnoses expected annually and approximately 18.6 million cancer survivors, the United States maintains a large recurring treatment population.

Large-volume pumps are used within infusion facilities, while ambulatory pumps allow selected regimens to continue after patients leave. Oncology buyers prioritize accuracy, protocol support, closed-system workflow compatibility, patient mobility, and reliable device availability. Growth will also be supported by expansion of community oncology networks and freestanding infusion centers.

Critical Care, Emergency Medicine, and Surgery

Critical care represents one of the most pump-intensive applications. Patients may receive several simultaneous infusions, including vasopressors, sedatives, analgesics, antibiotics, insulin, anticoagulants, and fluids. High channel density and complex titration create a strong need for standardization, clear line management, accurate low-flow delivery, and dependable alarms.

Operating rooms and anesthesia departments require syringe, volumetric, and specialty pumps for controlled medication and fluid administration. Procurement decisions in these areas are strongly influenced by usability, device footprint, battery reliability, rapid setup, and integration with anesthesia or hospital information systems.

Pain Management and Anesthesia

Infusion pumps are used for patient-controlled analgesia, epidural therapy, regional anesthesia, chronic pain management, and palliative care. Safety features are especially important because opioids and local anesthetics can cause severe harm when programmed incorrectly or delivered to the wrong route.

Demand is moving toward pumps with configurable dose limits, lockout periods, secure access, respiratory-monitoring integration, and detailed event records. Ambulatory pain pumps are also used following selected surgical procedures to support earlier discharge and reduce reliance on systemic opioids.

Gastroenterology, Nutrition, Infectious Disease, and Other Chronic Therapies

This application category includes parenteral nutrition, enteral feeding, long-duration antibiotic therapy, immune globulin, biologics, pulmonary hypertension drugs, hydration, and therapies for neurological or gastrointestinal disease. Many treatments require extended administration and are suitable for ambulatory or home settings.

The segment is strategically important because it connects device demand with the growth of specialty pharmacy and home infusion. Devices must accommodate diverse drugs, infusion durations, patient capabilities, and monitoring requirements. Manufacturers that support protocol flexibility and patient-friendly use will be positioned for above-average growth.

 

By Technology and Delivery Modality

Smart and Connected Infusion Pumps

Smart and connected pumps accounted for the largest technology share in 2025 and are expected to strengthen their position through 2035. These systems incorporate drug libraries, dose-error reduction, wireless connectivity, centralized software, event reporting, and electronic medical record integration.

Purchasing decisions increasingly focus on connectivity quality rather than the presence of connectivity alone. Hospitals want reliable auto-programming, accurate documentation, simplified software deployment, cybersecurity support, analytics, and evidence that the workflow reduces manual effort.

Traditional Programmable Pumps

Traditional programmable pumps remain in use across hospitals, clinics, long-term care, veterinary facilities, and resource-constrained settings. They offer controlled delivery but may lack comprehensive drug libraries, interoperability, or centralized management.

This segment will continue to generate replacement and service revenue, but its market share will decline as large institutions standardize connected platforms. Traditional systems will remain relevant where connectivity adds limited value or where acquisition cost and operational simplicity are dominant considerations.

Wearable and Patch-Based Pumps

Wearable systems include tubeless insulin pumps and emerging on-body drug-delivery devices. They enable patients to receive therapy while maintaining mobility and may reduce the need for conventional infusion chairs or tethered equipment.

This is expected to be the fastest-growing technology category. Growth will be supported by automated insulin delivery and pharmaceutical-device combinations for high-volume subcutaneous biologics. Successful devices must balance wearability, comfort, reservoir volume, adhesion, delivery accuracy, connectivity, and manufacturing economics.

Disposable and Elastomeric Pumps

Disposable pumps offer portability and simple operation without electronic programming. They are attractive for selected home antibiotic, analgesic, and chemotherapy applications. Their growth is linked to outpatient care migration and demand for devices that require minimal maintenance.

However, reimbursement differences, environmental waste, flow-rate limitations, and lack of electronic records can constrain adoption. The segment will remain clinically important but will not replace electronic pumps for complex or frequently adjusted therapies.

Implantable Infusion Technologies

Implantable pumps provide targeted or long-duration delivery for selected patients with chronic pain, spasticity, or cancer-related indications. These systems can reduce systemic drug exposure but require implantation, refill procedures, specialist expertise, and long-term surveillance.

Market growth will be moderate because of the specialized patient pool and procedural requirements. Innovation will focus on reliability, reservoir life, programming, dose precision, and improved patient-selection tools.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems are the dominant end users, accounting for the largest share of large-volume, syringe, and patient-controlled analgesia pump demand. The country’s approximately 6,100 hospitals and 907,000 staffed beds create a substantial installed base and recurring requirement for replacement, service, software, and administration sets.

Integrated delivery networks increasingly negotiate enterprise contracts covering several hospitals and multiple pump types. Their decisions are influenced by total lifecycle economics, safety performance, interoperability, disposable pricing, cybersecurity, implementation support, and supplier stability.

Ambulatory Infusion Centers and Outpatient Departments

Hospital outpatient departments, physician-owned centers, and freestanding infusion facilities administer oncology drugs, biologics, hydration, antibiotics, immune therapies, and other specialty medications. Growth is supported by rising specialty drug utilization and payer interest in lower-cost infusion settings.

These facilities prioritize throughput, chair utilization, reliable scheduling, protocol flexibility, and efficient documentation. Pumps that are easy to clean, rapidly deployable, and compatible with high-volume workflows are likely to gain preference.

Home Infusion Providers and Specialty Pharmacies

Home infusion providers and specialty pharmacies represent the fastest-growing institutional end-user segment. Medicare’s home infusion benefit and commercial payer site-of-care programs support selected intravenous or subcutaneous therapies administered through qualifying pumps.

Providers require devices that can be delivered, programmed, taught, monitored, serviced, and retrieved efficiently. Supplier responsiveness and patient support are critical because equipment failure outside the facility may interrupt essential treatment.

Diabetes Clinics, Physician Practices, and Retail Channels

Endocrinology practices, diabetes educators, primary care providers, pharmacies, distributors, and durable medical equipment suppliers influence insulin pump adoption. Manufacturers must support clinical training, benefits verification, prescription processing, onboarding, data sharing, and ongoing patient assistance.

Consumer experience has become a major competitive factor. Patients evaluate device visibility, comfort, ease of wear, smartphone compatibility, alarm burden, sensor integration, customer service, and out-of-pocket cost alongside clinical performance.

Long-Term Care, Skilled Nursing, and Other Care Settings

Long-term care facilities, skilled nursing facilities, rehabilitation centers, hospice providers, and other care environments use infusion pumps for hydration, antibiotics, nutrition, pain management, and chronic therapy. These facilities often operate with constrained staffing and require equipment that is intuitive, durable, and supported by dependable service.

Growth will be moderate but stable. Manufacturers and rental providers that simplify training and offer flexible fleet arrangements can perform well in this segment.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Infusion Pumps Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand varies according to population size, hospital capacity, diabetes prevalence, cancer burden, older adult concentration, specialty pharmacy activity, home infusion penetration, payer mix, health system consolidation, and technology adoption.

The South represented the largest regional market in 2025, while the West is expected to achieve the fastest growth through 2035. The Northeast remains the highest-value region on a per-patient and per-facility basis, while the Midwest provides a stable installed base of large hospital systems, academic centers, home infusion providers, and medical technology expertise.

South

The South accounted for an estimated USD 2.43 billion in 2025 and represented approximately 36% of the U.S. market. At an estimated regional CAGR of about 8.4%, the Southern market could reach approximately USD 5.44 billion by 2035.

The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and the District of Columbia. Its market leadership is supported by population scale, rapid demographic growth, elevated diabetes burden, large older adult populations, expanding hospital networks, and strong oncology and specialty pharmacy demand.

Texas is the largest Southern state market. Houston, Dallas-Fort Worth, Austin, and San Antonio contain extensive hospital systems, cancer centers, children’s hospitals, transplant programs, and home infusion networks. Texas is attractive for enterprise pump contracts because major health systems operate multiple acute-care and outpatient facilities across large geographic areas. The state also has a meaningful rural population, supporting demand for portable treatment and regional care coordination.

Florida is another major market due to its large older adult population and Medicare exposure. Demand is supported by oncology, chronic disease management, home infusion, enteral feeding, pain management, and insulin delivery. Large health systems and retirement-related population growth make Florida particularly important for connected pumps and patient-friendly home technologies.

North Carolina is strategically significant because of its expanding population, academic health centers, research ecosystem, and medical manufacturing infrastructure. Charlotte, Raleigh-Durham, Winston-Salem, and other metropolitan areas support hospital modernization and specialty care growth. The state’s experience with intravenous supply disruption has also increased attention to infusion supply-chain resilience.

Georgia, Tennessee, and Virginia are growing markets supported by large metropolitan hospital networks and regional referral centers. Atlanta, Nashville, Richmond, Northern Virginia, and Hampton Roads maintain strong demand across critical care, oncology, surgery, pediatrics, and home infusion. Tennessee is particularly important for healthcare services companies, while Virginia benefits from federal, military, academic, and commercial healthcare infrastructure.

Maryland and the District of Columbia have smaller populations but high concentrations of advanced hospitals, federal research institutions, academic centers, and complex care. These markets often require strong cybersecurity, clinical evidence, and interoperability capabilities.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma carry substantial chronic disease burdens and contain many rural or medically underserved areas. Large urban referral hospitals create demand for premium connected systems, while rural markets require service reliability, equipment availability, and practical ambulatory solutions. Limited specialist access can slow adoption of advanced insulin technologies in some communities, creating opportunities for remote onboarding and virtual support.

The South will remain the largest regional market through 2035. Growth will be driven by hospital construction, system consolidation, diabetes technology, cancer treatment, home infusion, and movement into lower-cost outpatient settings.

West

The West generated an estimated USD 1.48 billion in 2025. With a projected CAGR approaching 8.9%, the regional market could reach approximately USD 3.47 billion by 2035, making it the fastest-growing U.S. region.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Growth is supported by population expansion in several states, strong technology adoption, leading academic medical centers, digital health infrastructure, and a significant base of medical device innovators.

California is the largest Western state market and one of the most important infusion pump markets nationally. Its personal healthcare spending is the highest of any state, reflecting its population size and extensive provider infrastructure. California contains major academic medical centers, integrated health systems, oncology networks, biotechnology companies, diabetes technology developers, and home infusion providers.

Provider systems in California are often early adopters of interoperability, analytics, and connected care. The state is also commercially important for wearable insulin pumps and on-body drug-delivery technologies because of its technology-oriented patient population and concentration of innovation partners.

Arizona and Nevada are high-growth markets because of rapid population expansion and increasing older adult populations. Phoenix, Tucson, Las Vegas, and Reno are adding hospital and specialty care capacity. Demand is expected to rise for oncology infusion, diabetes technology, enteral pumps, and home-based chronic therapy.

Washington and Oregon have sophisticated integrated delivery networks and strong adoption of standardized clinical technology. Seattle and Portland support academic medicine, cancer care, digital health, and enterprise information technology. Procurement in these states frequently emphasizes interoperability, cybersecurity, sustainability, and population health.

Colorado and Utah have expanding populations, strong hospital systems, and growing technology ecosystems. Colorado has demonstrated adoption of advanced infusion platforms across both metropolitan and regional providers. Utah combines a relatively young population with strong health system integration and technology-oriented care delivery.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller state markets but have distinct needs related to rural geography, patient travel, workforce availability, and supply logistics. Portable pumps and home infusion can create particular value where repeated travel to specialty facilities is difficult. However, service coverage, equipment retrieval, emergency backup, and reliable distribution are essential.

The West is expected to gain national market share as infusion care becomes more connected, patient-centered, and decentralized. Its innovation ecosystem also makes the region an important testing ground for new wearable devices, digital support models, and pharmaceutical-device combinations.

Northeast

The Northeast represented approximately USD 1.50 billion in 2025 and is projected to reach around USD 3.21 billion by 2035, based on an estimated regional CAGR of approximately 7.9%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine. Delaware and Maryland may be classified with either the Northeast or South in different market frameworks; this report assigns them to the South for consistency.

The Northeast has some of the highest per-capita healthcare spending in the country and a dense concentration of academic hospitals, cancer centers, children’s hospitals, research institutions, specialty pharmacies, and high-acuity referral programs. Although population growth is slower than in the South and West, procedure complexity and premium technology adoption support high revenue per facility.

New York is the largest Northeastern state market. The New York metropolitan area contains large health systems with extensive pump fleets and complex electronic medical record environments. Upstate hospital networks also generate demand across urban and rural settings. Procurement committees in New York generally require strong safety evidence, implementation planning, cybersecurity review, and financial justification.

Pennsylvania has a substantial hospital and life sciences base. Philadelphia and Pittsburgh contain nationally recognized academic and specialty centers, while regional systems support broad community demand. The state is important for oncology, pediatrics, critical care, home infusion, and specialty pharmaceuticals.

New Jersey combines high healthcare spending, pharmaceutical industry concentration, specialty pharmacy activity, and access to the New York and Philadelphia markets. The state is especially relevant for pharmaceutical-device partnerships and on-body delivery innovation.

Massachusetts has a smaller population than New York or Pennsylvania but remains highly influential. Boston’s academic hospitals and biotechnology ecosystem frequently evaluate new infusion technologies, clinical software, and drug-delivery platforms. Adoption decisions made by leading Massachusetts institutions can influence broader U.S. purchasing and clinical practice.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine offer smaller but stable opportunities. Aging populations support home infusion, enteral feeding, chronic disease management, and oncology demand. Rural areas of northern New England require reliable distribution and remote support.

The Northeast will remain one of the most profitable regions because of high-acuity care, complex therapy, strong research activity, and premium technology adoption. Growth may be moderated by mature installed bases and slower population expansion.

Midwest

The Midwest accounted for an estimated USD 1.27 billion in 2025 and is projected to reach approximately USD 2.64 billion by 2035, reflecting an estimated CAGR of about 7.6%.

The region includes Illinois, Ohio, Michigan, Minnesota, Wisconsin, Indiana, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. Demand is supported by large academic centers, established community hospital networks, chronic disease burden, medical device manufacturing expertise, and strong regional referral systems.

Illinois is the largest Midwestern market. Chicago contains major academic hospitals, children’s hospitals, oncology programs, and integrated delivery networks. The remainder of the state includes community and rural providers requiring cost-effective and serviceable pump fleets.

Ohio has a highly developed hospital infrastructure across Cleveland, Columbus, Cincinnati, Dayton, and other cities. Large health systems create opportunities for enterprise smart pump contracts, while oncology and home infusion networks support ambulatory demand.

Michigan generates substantial demand across Detroit, Ann Arbor, Grand Rapids, and regional markets. The state’s chronic disease burden supports insulin pump and cardiovascular medication delivery, while academic and pediatric facilities require advanced syringe and large-volume systems.

Minnesota is strategically important because of its medical technology heritage, major health systems, and infusion pump expertise. A multiyear agreement involving the planned purchase of approximately 10,000 advanced large-volume pumps for facilities in Minnesota, Arizona, and Florida illustrates the scale of enterprise purchasing decisions originating from leading Midwestern providers.

Wisconsin, Indiana, Missouri, Iowa, and Kansas offer stable demand across hospitals, oncology centers, specialty pharmacies, and long-term care. Procurement frequently emphasizes reliability, service responsiveness, training, and total cost of ownership.

Nebraska, North Dakota, and South Dakota are smaller markets with geographically dispersed populations. Regional referral systems and home infusion can reduce travel requirements, but suppliers must provide dependable logistics and support. Remote fleet management and virtual patient education may create disproportionate value in these states.

The Midwest is unlikely to outgrow the West or South, but it will remain an important market for established pump categories, hospital fleet modernization, home infusion, and clinical evidence generation.

 

Key Market Players

The U.S. Infusion Pumps Competitive Landscape is moderately consolidated in institutional smart pumps and increasingly competitive in wearable insulin delivery, ambulatory infusion, home therapy, and on-body drug delivery.

Large hospital contracts are concentrated among manufacturers capable of supplying pumps, proprietary administration sets, safety software, implementation services, cybersecurity support, maintenance, and nationwide distribution. Diabetes-focused companies compete through automated dosing, wearable design, recurring consumables, sensor partnerships, and patient support. Specialty manufacturers address ambulatory therapy, enteral nutrition, elastomeric delivery, implantable pumps, and high-volume subcutaneous biologics.

Some of the key players in the U.S. Infusion Pumps industry are:

Baxter International

Becton, Dickinson and Company

• ICU Medical
• B. Braun Medical
• Fresenius Kabi
• Medtronic
• Insulet Corporation
• Tandem Diabetes Care
• MiniMed
• Terumo Corporation
• Nipro Corporation
• Moog Medical
• Eitan Medical
• KORU Medical Systems
• Avanos Medical
• CODAN Companies
• Zyno Medical
• InfuSystem Holdings
• SOOIL Development
• Sequel Med Tech
• Ypsomed
• Enable Injections
• West Pharmaceutical Services
• Gerresheimer
• United Therapeutics

Baxter, BD, ICU Medical, B. Braun, and Fresenius Kabi are among the principal competitors in hospital infusion systems. Their competitive positions depend on installed base, administration-set revenue, electronic medical record interoperability, drug-library software, clinical support, and national contracting relationships.

Insulet, Tandem Diabetes Care, MiniMed, Sequel Med Tech, SOOIL, and Ypsomed participate in the connected insulin delivery ecosystem. Competition in this category is shaped by automated dosing performance, sensor compatibility, wearability, patient preference, reimbursement, and recurring consumable economics.

Moog Medical, Eitan Medical, KORU Medical Systems, Avanos Medical, CODAN, Zyno Medical, and InfuSystem address ambulatory, pain, home infusion, specialty delivery, service, rental, and related niches. Enable Injections, West Pharmaceutical Services, and Gerresheimer represent the emerging on-body delivery opportunity linked to pharmaceutical partnerships.

Market share through 2035 will be influenced by FDA clearances, quality-system performance, recall management, software reliability, cybersecurity, supply continuity, electronic record integration, group purchasing organization contracts, and manufacturer implementation capacity. Companies that reduce medication risk and nursing workload while demonstrating predictable lifecycle costs will be best positioned to defend premium pricing.

 

Recent Developments

Recent developments in the U.S. Infusion Pumps Market demonstrate that the competitive cycle is being shaped simultaneously by platform innovation, regulatory remediation, interoperability, and device-safety concerns.

In 2025, ICU Medical received U.S. regulatory clearances for its Plum Solo precision intravenous pump and updated versions of the Plum Duo pump and LifeShield infusion safety software. The platform introduced single- and dual-channel configurations, centralized management, electronic health record interoperability, and delivery accuracy designed to remain consistent under varied clinical conditions. The launch intensified competition among hospital smart pump suppliers.

BD continued the commercial and regulatory progression of its updated Alaris Infusion System. The company received clearance for an updated system in 2023 and an additional clearance in April 2025. Alaris remains strategically important because its modular architecture can support large-volume, syringe, and patient-controlled analgesia applications through a centralized interface. Health system purchasing decisions will continue to depend on remediation progress, service execution, and confidence in long-term platform support.

Baxter received FDA clearance for the Novum IQ large-volume pump and associated Dose IQ safety software in April 2024, following earlier clearance of its Novum IQ syringe pump. The system was designed to expand Baxter’s connected infusion portfolio. However, a serious 2025 correction involving Novum IQ large-volume and syringe pumps reinforced the operational and commercial impact of software and performance issues in high-risk devices.

Baxter also presented real-world data in December 2025 involving approximately 1.3 million infusions across six hospitals. The analysis indicated that electronic medical record integration was associated with fewer dose-error reduction alerts and a reduction in median pump programming time. This development is commercially significant because hospitals increasingly require measurable workflow evidence when approving connected pump investments.

Fresenius Kabi has continued expanding deployment of the Ivenix Infusion System in the United States. A major multiyear agreement announced with Mayo Clinic involved an expected purchase of approximately 10,000 large-volume pumps for hospitals and clinics in Minnesota, Arizona, and Florida. The transaction illustrates the scale and multiregional character of enterprise pump replacement projects.

Automated insulin delivery entered a broader commercial phase after FDA clearance of the first automated insulin dosing system for adults with type 2 diabetes in August 2024. This milestone expanded the potential role of pump therapy beyond its traditional type 1 diabetes base and encouraged greater competition around simplified onboarding, tubeless systems, glucose sensor connectivity, and payer coverage.

Device safety remains a material risk. During 2026, FDA communications identified serious recalls involving certain Omnipod products because of potential insulin under-delivery associated with tubing defects. These events demonstrate that growth in wearable pumps must be matched by manufacturing quality, lot traceability, rapid customer communication, replacement logistics, and contingency planning.

Cybersecurity requirements are also strengthening. Manufacturers are being evaluated on their ability to identify vulnerabilities, issue patches, support secure hospital deployment, and maintain software throughout the device lifecycle. This is changing research and development economics because connected pump manufacturers must maintain ongoing software and security capabilities after the initial hardware sale.

Supply-chain resilience has become another strategic development area. Disruption affecting intravenous solution manufacturing and continued concern about imported medical equipment have encouraged hospitals and manufacturers to reassess domestic capacity, supplier concentration, inventory buffers, and continuity plans. Because pump platforms can depend on proprietary sets and cassettes, consumable availability is now evaluated alongside pump functionality.

The market is also moving toward closer collaboration between pharmaceutical and device companies. On-body delivery systems for large-volume subcutaneous biologics may enable selected treatments to migrate from infusion centers to patient homes. These partnerships are expected to become an important source of innovation during the forecast period, although commercial success will require synchronized drug and device development.

 

Conclusion

The U.S. Infusion Pumps Market Size & Share is positioned to expand from approximately USD 6.68 billion in 2025 to USD 14.76 billion by 2035, representing a CAGR of 8.25% during the forecast period.

The market’s long-term strength is based on the essential role of controlled medication delivery, the size of the U.S. hospital system, high diabetes and cancer burden, increasing specialty drug utilization, infusion pump replacement cycles, and the migration of treatment into ambulatory and home environments.

The most attractive institutional opportunities will be concentrated in interoperable large-volume pumps, advanced syringe pumps, centralized infusion software, drug-library analytics, and cybersecurity services. In diabetes care, automated insulin delivery, tubeless pumps, continuous glucose monitor integration, and expansion into insulin-requiring type 2 diabetes will generate substantial value.

Home infusion and ambulatory delivery will create opportunities for portable pumps, patient-friendly interfaces, specialty pharmacy partnerships, remote support, and recurring service models. On-body delivery systems for biologics could create an additional growth layer by shifting selected therapies away from conventional intravenous infusion.

Regional demand will be led by the South because of population scale, chronic disease burden, hospital expansion, and older adult growth. The West will achieve the fastest expansion due to demographic growth and early adoption of connected and wearable technology. The Northeast will remain a premium, evidence-driven market, while the Midwest will provide stable demand and influential enterprise procurement opportunities.

The market will nevertheless remain exposed to device recalls, quality-system deficiencies, cybersecurity vulnerabilities, proprietary consumable dependency, nursing resistance to poorly designed workflows, and reimbursement variation. A technically advanced pump will not achieve sustainable adoption unless it performs reliably in daily clinical practice and is supported by effective implementation.

For manufacturers, investors, health systems, pharmaceutical companies, and distributors evaluating this market, the central strategic question is not simply how many pumps will be purchased. The more important issues are which platforms will become embedded in enterprise medication workflows, which companies will control recurring consumable revenue, how automated insulin delivery will expand, and which technologies will enable treatment to move safely into lower-cost settings.

Companies that combine dependable delivery, intuitive operation, interoperability, cybersecurity, clinical evidence, supply continuity, and measurable workflow improvement will define the next decade of the U.S. infusion pumps industry.

 

TABLE OF CONTENT

1. U.S. Infusion Pumps Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Infusion Pump Manufacturers
1.6.2. Pump Component and Contract Manufacturing Suppliers
1.6.3. Administration Set, Cassette, Reservoir, and Disposable Suppliers
1.6.4. Pharmaceutical and Specialty Drug Manufacturers
1.6.5. Hospitals and Integrated Delivery Networks
1.6.6. Ambulatory Infusion Centers and Oncology Clinics
1.6.7. Home Infusion Providers and Specialty Pharmacies
1.6.8. Diabetes Clinics, Endocrinologists, and Patient Support Networks
1.6.9. Group Purchasing Organizations and Medical Device Distributors
1.6.10. Payers, Regulators, and Medication-Safety Decision-Makers

What this section provides: This section defines the U.S. infusion pumps market boundary, study scope, research methodology, assumptions, revenue inclusions, exclusions, and stakeholder ecosystem so clients understand how the market is measured, segmented, validated, and forecast.

2. U.S. Infusion Pumps Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, Growth Rate, and Revenue Opportunity
2.8. Leading Product, Application, Technology, and End-User Segments
2.9. High-Growth Opportunity Areas
2.10. Critical Success Factors for Market Participants

What this section provides: This section gives decision-makers a concise view of market size, historical development, forecast direction, leading segments, competitive intensity, adoption priorities, and high-growth opportunities in the U.S. infusion pumps industry.

3. U.S. Infusion Pumps Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Replacement of Aging Hospital Infusion Pump Fleets
3.1.2. Rising Demand for Smart and Connected Infusion Systems
3.1.3. Expansion of Automated Insulin Delivery
3.1.4. Growing U.S. Diabetes and Chronic Disease Burden
3.1.5. Increasing Oncology and Specialty Drug Infusion Volumes
3.1.6. Migration of Infusion Therapy to Ambulatory and Home Settings
3.1.7. Demand for Electronic Medical Record Interoperability
3.1.8. Medication-Safety and Dose-Error Reduction Requirements
3.1.9. Hospital Nursing Shortages and Workflow Automation
3.1.10. Growth of Specialty Pharmacies and Home Infusion Networks
3.2. Restraints and Their Impact Analysis
3.2.1. High Smart Pump Acquisition and Implementation Costs
3.2.2. Product Recalls, Corrections, and Quality-System Risk
3.2.3. Cybersecurity Vulnerabilities in Connected Infusion Devices
3.2.4. Alarm Fatigue and Clinical Workflow Complexity
3.2.5. Proprietary Administration Set and Consumable Dependency
3.2.6. Reimbursement Variability Across Infusion Sites of Care
3.2.7. Extended Hospital Procurement and Validation Cycles
3.2.8. Training Burden Associated with Enterprise Pump Conversion
3.3. Opportunities and Their Impact Analysis
3.3.1. Bidirectional Electronic Health Record Integration
3.3.2. Automated Insulin Delivery for Type 2 Diabetes
3.3.3. Expansion of Home Infusion and Hospital-at-Home Programs
3.3.4. Wearable and On-Body Biologic Delivery Systems
3.3.5. Cloud-Based Drug-Library and Fleet Management
3.3.6. Infusion Analytics and Medication-Safety Intelligence
3.3.7. Low-Flow Precision for Neonatal and Critical Care Applications
3.3.8. Pharmaceutical-Device Combination Partnerships
3.3.9. Remote Pump Support and Patient Monitoring
3.3.10. Domestic Manufacturing and Supply-Chain Localization
3.4. Challenges and Their Impact Analysis
3.4.1. Maintaining Drug-Library Accuracy and Standardization
3.4.2. Integrating Pumps Across Multiple Electronic Medical Record Environments
3.4.3. Balancing Connectivity with Cybersecurity Requirements
3.4.4. Managing Disposable Supply Continuity
3.4.5. Demonstrating Clinical and Economic Value to Hospital Committees
3.4.6. Supporting Patients and Caregivers in Home Settings
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Infusion Workflow Economics Analysis
3.6.1. Pump Programming Time and Nursing Productivity
3.6.2. Dose-Error Prevention and Avoidable Adverse Event Costs
3.6.3. Alarm Burden and Clinical Response Efficiency
3.6.4. Pump Utilization, Availability, and Fleet Optimization
3.6.5. Consumable Standardization and Recurring Supply Costs
3.6.6. Hospital-to-Home Infusion Cost Comparison
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Enterprise Pump Replacement Decision Criteria
3.7.2. Multidisciplinary Value Analysis Committee Requirements
3.7.3. Total Cost of Ownership Assessment
3.7.4. Clinical Simulation and Usability Evaluation
3.7.5. Cybersecurity and Information Technology Review
3.7.6. Vendor Standardization and Multiyear Contracting

What this section provides: This section explains the clinical, commercial, technological, reimbursement, safety, and operational forces shaping U.S. infusion pump demand, helping clients assess growth opportunities, adoption barriers, procurement priorities, and execution risks.

4. U.S. Infusion Pumps Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and Health System Buyers
4.2.3. Bargaining Power of Component and Disposable Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Pump Hardware Pricing
4.3.2. Proprietary Administration Set and Disposable Pricing
4.3.3. Software, Connectivity, and Analytics Pricing
4.3.4. Maintenance and Service Contract Pricing
4.3.5. Insulin Pump and Recurring Consumable Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Materials and Electronic Components
4.4.2. Pump Hardware Manufacturing
4.4.3. Software and Connectivity Development
4.4.4. Sterile Disposable Manufacturing
4.4.5. Distribution and Group Purchasing Organizations
4.4.6. Hospitals, Clinics, Pharmacies, and Home Infusion Providers
4.4.7. Patients and Caregivers
4.5. Impact of Digitalization and Connected Medication Delivery
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Infusion Pump Premarket Requirements
4.7.2. Human Factors and Usability Engineering
4.7.3. Software and Cybersecurity Documentation
4.7.4. Combination Product Considerations
4.7.5. Medical Device Reporting and Recall Requirements
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Durable Medical Equipment Coverage
4.8.2. Home Infusion Therapy Benefit
4.8.3. Insulin Pump Coverage
4.8.4. Enteral and Parenteral Nutrition Coverage
4.8.5. Hospital Outpatient and Ambulatory Infusion Reimbursement
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Medication-Safety Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Safety and Accuracy
4.12.2. Interoperability and Information Technology Compatibility
4.12.3. Nursing Workflow and Ease of Use
4.12.4. Drug-Library and Pharmacy Governance
4.12.5. Cybersecurity and Software Support
4.12.6. Capital Cost and Consumable Economics
4.12.7. Serviceability and Supply Continuity

What this section provides: This section gives clients a complete view of the U.S. infusion pump operating environment, including regulation, reimbursement, pricing, digitalization, supply chains, cybersecurity, procurement economics, and hospital value-analysis requirements.

5. U.S. Infusion Pumps Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Large-Volume and Volumetric Infusion Pumps
5.1.2.1. Standalone Large-Volume Pumps
5.1.2.2. Modular and Multi-Channel Infusion Systems
5.1.2.3. Enteral-Compatible Volumetric Systems
5.1.3. Syringe Infusion Pumps
5.1.3.1. General-Purpose Syringe Pumps
5.1.3.2. Critical Care Syringe Pumps
5.1.3.3. Neonatal and Pediatric Syringe Pumps
5.1.3.4. Anesthesia Syringe Pumps
5.1.4. Insulin Pumps
5.1.4.1. Durable Tethered Insulin Pumps
5.1.4.2. Tubeless and Patch Insulin Pumps
5.1.4.3. Automated Insulin Delivery Systems
5.1.4.4. Insulin Pump Infusion Sets, Pods, Reservoirs, and Cartridges
5.1.5. Ambulatory Infusion Pumps
5.1.5.1. Chemotherapy Infusion Pumps
5.1.5.2. Antibiotic Infusion Pumps
5.1.5.3. Pain Management Infusion Pumps
5.1.5.4. Parenteral Nutrition Infusion Pumps
5.1.5.5. Specialty Drug Infusion Pumps
5.1.6. Patient-Controlled Analgesia Pumps
5.1.6.1. Intravenous PCA Pumps
5.1.6.2. Epidural and Regional Analgesia Pumps
5.1.7. Enteral Feeding Pumps
5.1.7.1. Hospital Enteral Feeding Pumps
5.1.7.2. Home Enteral Feeding Pumps
5.1.7.3. Portable Enteral Feeding Pumps
5.1.8. Elastomeric and Disposable Infusion Pumps
5.1.8.1. Continuous-Rate Elastomeric Pumps
5.1.8.2. Variable-Rate Elastomeric Pumps
5.1.8.3. Patient-Controlled Disposable Pumps
5.1.9. Implantable Infusion Pumps
5.1.9.1. Intrathecal Pain Pumps
5.1.9.2. Spasticity Management Pumps
5.1.9.3. Implantable Oncology Infusion Pumps
5.1.10. On-Body and Specialty Drug-Delivery Pumps
5.1.10.1. Large-Volume Subcutaneous Delivery Systems
5.1.10.2. Biologic Drug-Delivery Pumps
5.1.10.3. Drug-Device Combination Delivery Systems

What this section provides: This section identifies the infusion pump product categories and subcategories expected to generate the strongest revenue contribution, recurring consumable demand, replacement activity, and technology-led growth through 2035.

6. U.S. Infusion Pumps Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Diabetes Management
6.1.2.1. Type 1 Diabetes
6.1.2.2. Insulin-Requiring Type 2 Diabetes
6.1.2.3. Pediatric Diabetes Management
6.1.2.4. Automated Insulin Delivery
6.1.3. Oncology and Hematology
6.1.3.1. Chemotherapy
6.1.3.2. Immunotherapy
6.1.3.3. Targeted Therapy and Biologics
6.1.3.4. Hematology and Blood Product Infusion
6.1.3.5. Supportive Oncology Care
6.1.4. Critical Care and Emergency Medicine
6.1.4.1. Vasoactive Drug Delivery
6.1.4.2. Sedation and Analgesia
6.1.4.3. Antibiotic and Anticoagulant Delivery
6.1.4.4. Fluid and Electrolyte Management
6.1.4.5. Neonatal and Pediatric Critical Care
6.1.5. Surgery, Anesthesia, and Postoperative Care
6.1.5.1. General Anesthesia
6.1.5.2. Regional Anesthesia
6.1.5.3. Perioperative Fluid Management
6.1.5.4. Postoperative Pain Management
6.1.6. Pain Management and Palliative Care
6.1.6.1. Patient-Controlled Analgesia
6.1.6.2. Chronic Pain Management
6.1.6.3. Intrathecal Drug Delivery
6.1.6.4. Hospice and Palliative Care
6.1.7. Gastroenterology and Clinical Nutrition
6.1.7.1. Enteral Nutrition
6.1.7.2. Total Parenteral Nutrition
6.1.7.3. Short Bowel Syndrome Management
6.1.7.4. Gastrointestinal Disease Support
6.1.8. Infectious Disease Management
6.1.8.1. Long-Term Antibiotic Therapy
6.1.8.2. Antiviral and Antifungal Infusion
6.1.8.3. Outpatient Parenteral Antimicrobial Therapy
6.1.9. Immunology, Neurology, and Other Specialty Therapies
6.1.9.1. Immunoglobulin Therapy
6.1.9.2. Neurological Disease Therapy
6.1.9.3. Pulmonary Hypertension Therapy
6.1.9.4. Autoimmune Disease Treatment
6.1.9.5. Rare Disease and Biologic Therapy

What this section provides: This section helps clients understand infusion pump demand by clinical use case and identify applications with high treatment volumes, strong recurring consumable requirements, favorable site-of-care migration, and meaningful technology adoption.

7. U.S. Infusion Pumps Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic Medical Centers
7.1.2.2. Community Hospitals
7.1.2.3. Critical Access Hospitals
7.1.2.4. Children’s Hospitals
7.1.2.5. Specialty Hospitals
7.1.3. Ambulatory Infusion Centers and Hospital Outpatient Departments
7.1.3.1. Hospital-Owned Infusion Centers
7.1.3.2. Freestanding Infusion Centers
7.1.3.3. Physician-Owned Infusion Suites
7.1.4. Oncology and Hematology Clinics
7.1.4.1. Community Oncology Practices
7.1.4.2. Comprehensive Cancer Centers
7.1.4.3. Hematology Treatment Centers
7.1.5. Home Infusion Providers and Specialty Pharmacies
7.1.5.1. National Home Infusion Providers
7.1.5.2. Regional Home Infusion Providers
7.1.5.3. Health System-Owned Home Infusion Programs
7.1.5.4. Specialty Pharmacy Infusion Services
7.1.6. Diabetes Clinics and Physician Practices
7.1.6.1. Endocrinology Practices
7.1.6.2. Primary Care Practices
7.1.6.3. Diabetes Education Centers
7.1.6.4. Pediatric Diabetes Centers
7.1.7. Ambulatory Surgery Centers
7.1.7.1. Multispecialty Ambulatory Surgery Centers
7.1.7.2. Orthopedic and Pain Management Centers
7.1.7.3. Gastrointestinal and Specialty Procedure Centers
7.1.8. Long-Term Care and Skilled Nursing Facilities
7.1.8.1. Skilled Nursing Facilities
7.1.8.2. Assisted Living Facilities
7.1.8.3. Rehabilitation Centers
7.1.8.4. Hospice and Palliative Care Providers
7.1.9. Homecare Patients and Individual Users
7.1.9.1. Insulin Pump Users
7.1.9.2. Home Antibiotic Therapy Patients
7.1.9.3. Home Nutrition Therapy Patients
7.1.9.4. Home Biologic and Specialty Drug Patients
7.1.10. Research, Military, and Other Healthcare Facilities

What this section provides: This section explains which U.S. care settings, institutional buyers, clinical providers, and patient groups are expected to drive infusion pump procurement, recurring disposable use, software adoption, and decentralized treatment demand.

8. U.S. Infusion Pumps Market – By Technology and Delivery Modality

8.1. Overview
8.1.1. Segment Share Analysis, By Technology and Delivery Modality, 2025 & 2035 (%)
8.1.2. Smart and Connected Infusion Pumps
8.1.2.1. Dose-Error Reduction Systems
8.1.2.2. Wireless Drug-Library Management
8.1.2.3. Electronic Medical Record Auto-Programming
8.1.2.4. Automatic Infusion Documentation
8.1.2.5. Centralized Fleet and Software Management
8.1.3. Traditional Programmable Infusion Pumps
8.1.3.1. Standalone Electronic Pumps
8.1.3.2. Non-Interoperable Programmable Pumps
8.1.3.3. Basic Volumetric and Syringe Pumps
8.1.4. Wearable and Patch-Based Pumps
8.1.4.1. Tubeless Insulin Pumps
8.1.4.2. Wearable Automated Insulin Delivery Systems
8.1.4.3. On-Body Biologic Delivery Systems
8.1.4.4. Large-Volume Subcutaneous Pumps
8.1.5. Ambulatory Electronic Infusion Technologies
8.1.5.1. Portable Cassette-Based Pumps
8.1.5.2. Reservoir-Based Ambulatory Pumps
8.1.5.3. Remote-Support-Enabled Ambulatory Pumps
8.1.6. Disposable and Elastomeric Delivery Technologies
8.1.6.1. Fixed-Rate Delivery
8.1.6.2. Variable-Rate Delivery
8.1.6.3. Patient-Controlled Disposable Delivery
8.1.7. Implantable Infusion Technologies
8.1.7.1. Programmable Implantable Pumps
8.1.7.2. Constant-Flow Implantable Pumps
8.1.8. Software-Enabled and Analytics-Based Infusion Technologies
8.1.8.1. Infusion Safety Analytics
8.1.8.2. Drug-Library Compliance Analytics
8.1.8.3. Alarm and Workflow Analytics
8.1.8.4. Predictive Maintenance and Fleet Analytics
8.1.8.5. AI-Assisted Infusion Management

What this section provides: This section evaluates the technologies transforming infusion delivery, including smart pumps, interoperability, wearable systems, ambulatory platforms, disposable delivery, implantable pumps, analytics, and software-enabled medication workflows.

9. U.S. Infusion Pumps Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchase
9.1.2.2. Multiyear Platform Conversion Agreements
9.1.2.3. Pump and Consumable Bundled Contracts
9.1.2.4. Software and Service Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. System-Wide Pump Standardization
9.1.3.2. Multihospital Interoperability Contracts
9.1.3.3. Enterprise Drug-Library and Analytics Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional GPO Contracts
9.1.4.3. Aggregated Health System Purchasing
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. Medical-Surgical Distributors
9.1.5.2. Specialty Infusion Equipment Distributors
9.1.5.3. Durable Medical Equipment Suppliers
9.1.5.4. Diabetes Device Distributors
9.1.6. Specialty Pharmacy and Home Infusion Procurement
9.1.6.1. Direct Manufacturer Procurement
9.1.6.2. Pump Rental and Leasing
9.1.6.3. Therapy-Specific Equipment Programs
9.1.7. Retail Pharmacy and Pharmacy Benefit Channels
9.1.7.1. Insulin Pump Pharmacy Distribution
9.1.7.2. Automated Insulin Delivery Consumables
9.1.7.3. Patient Benefits Verification and Fulfillment
9.1.8. Online and Direct-to-Patient Channels
9.1.8.1. Manufacturer Direct Fulfillment
9.1.8.2. Subscription and Recurring Consumable Programs
9.1.8.3. Digital Patient Onboarding

What this section provides: This section helps clients understand how infusion pumps, software, services, and recurring disposables are purchased in the United States, including hospital contracts, IDN standardization, GPO influence, specialty pharmacy procurement, rental models, and direct-to-patient distribution.

10. U.S. Infusion Pumps Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Bed and Infusion Infrastructure Analysis
10.1.4. Regional Diabetes, Oncology, and Chronic Disease Demand Analysis
10.1.5. Regional Home Infusion and Specialty Pharmacy Penetration
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Smart Pump and Interoperability Adoption

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Infusion Pump Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Infusion Pump Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Infusion Pump Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Infusion Pump Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology and Delivery Modality, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states, helping clients identify hospital infusion hubs, diabetes and oncology demand centers, home infusion growth markets, smart pump adoption hotspots, and priority commercial opportunities.

11. U.S. Infusion Pumps Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Institutional Infusion Pump Market Share
11.1.2. Insulin Pump Market Share
11.1.3. Ambulatory and Home Infusion Pump Market Share
11.1.4. Enteral, Elastomeric, and Specialty Pump Market Share
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Product Portfolio Breadth
11.3.2. Installed Base and Recurring Consumable Revenue
11.3.3. Electronic Medical Record Interoperability
11.3.4. Drug-Library and Infusion Analytics Capabilities
11.3.5. Automated Insulin Delivery Capabilities
11.3.6. Home Infusion and Ambulatory Presence
11.3.7. Regulatory and Quality-System Performance
11.3.8. Cybersecurity and Software Support
11.3.9. U.S. Distribution and Service Infrastructure
11.4. Company Profiles
11.4.1. Baxter International
11.4.2. Becton, Dickinson and Company
11.4.3. ICU Medical
11.4.4. B. Braun Medical
11.4.5. Fresenius Kabi
11.4.6. Medtronic
11.4.7. Insulet Corporation
11.4.8. Tandem Diabetes Care
11.4.9. Sequel Med Tech
11.4.10. Ypsomed
11.4.11. SOOIL Development
11.4.12. Terumo Corporation
11.4.13. Nipro Corporation
11.4.14. Moog Medical
11.4.15. Eitan Medical
11.4.16. KORU Medical Systems
11.4.17. Avanos Medical
11.4.18. CODAN Companies
11.4.19. Zyno Medical
11.4.20. InfuSystem Holdings
11.4.21. Enable Injections
11.4.22. West Pharmaceutical Services
11.4.23. Gerresheimer
11.4.24. United Therapeutics
11.4.25. Cardinal Health

Note: Each company profile will include company overview, infusion pump and drug-delivery portfolio, U.S. market strategy, financial positioning, installed base, recurring consumable model, technology pipeline, regulatory updates, interoperability capabilities, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, installed-base intelligence, technology direction, regulatory exposure, and strategic analysis of leading U.S. infusion pump market participants.

12. U.S. Infusion Pumps Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Bidirectional Electronic Medical Record Interoperability
12.2.2. Automated Insulin Delivery and Closed-Loop Systems
12.2.3. Wearable and Tubeless Infusion Pumps
12.2.4. On-Body Large-Volume Biologic Delivery
12.2.5. Cloud-Based Infusion Management Platforms
12.2.6. AI-Assisted Infusion Analytics
12.2.7. Predictive Pump Maintenance and Fleet Optimization
12.2.8. Remote Home Infusion Monitoring
12.2.9. Advanced Low-Flow and Neonatal Infusion Technologies
12.3. Emerging Business Trends
12.3.1. Pump-as-a-Service and Managed Equipment Models
12.3.2. Bundled Pump, Disposable, Software, and Service Contracts
12.3.3. Pharmaceutical-Device Co-Development
12.3.4. Specialty Pharmacy and Manufacturer Partnerships
12.3.5. Direct-to-Patient Diabetes Device Distribution
12.3.6. Domestic Manufacturing and Supply-Chain Resilience
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. High-Growth, High-Attractiveness Opportunities
12.5.2. Stable, Recurring-Revenue Opportunities
12.5.3. Emerging Technology Opportunities
12.5.4. High-Risk or Capital-Intensive Opportunities
12.6. Market Consolidation and Partnership Outlook
12.7. Long-Term Competitive Structure

What this section provides: This section prepares clients for technology disruption, market structure changes, investment priorities, emerging commercial models, and realistic adoption scenarios influencing the U.S. infusion pumps market through 2035.

13. U.S. Infusion Pumps Market: Strategic Recommendations

13.1. Recommendations for Infusion Pump Manufacturers
13.1.1. Strengthen Smart Pump and Interoperability Capabilities
13.1.2. Improve Cybersecurity and Lifecycle Software Support
13.1.3. Expand Recurring Consumable and Service Revenue
13.1.4. Build Home Infusion and Ambulatory Product Portfolios
13.1.5. Demonstrate Medication-Safety and Workflow Economics
13.2. Recommendations for Hospitals and Health Systems
13.2.1. Standardize Drug Libraries and Clinical Profiles
13.2.2. Evaluate Total Cost of Ownership
13.2.3. Prioritize Usability and Nursing Workflow
13.2.4. Strengthen Connected Device Cybersecurity
13.2.5. Improve Pump Utilization and Fleet Visibility
13.3. Recommendations for Home Infusion Providers and Specialty Pharmacies
13.3.1. Select Patient-Friendly and Remotely Supportable Pumps
13.3.2. Strengthen Equipment Logistics and Backup Capacity
13.3.3. Integrate Pump Data with Pharmacy and Nursing Workflows
13.3.4. Develop Therapy-Specific Patient Support Programs
13.4. Recommendations for Investors and Private Equity Firms
13.4.1. Prioritize Recurring Consumable and Software Revenue Models
13.4.2. Evaluate Regulatory and Recall Exposure
13.4.3. Assess Installed-Base Retention and Switching Barriers
13.4.4. Identify Home Infusion and Wearable Delivery Opportunities
13.5. Recommendations for Distributors and Channel Partners
13.5.1. Expand Specialty Infusion and Diabetes Distribution
13.5.2. Develop Equipment Rental and Managed Fleet Services
13.5.3. Strengthen Regional Service and Consumable Availability
13.6. Recommendations for New Entrants and Startups
13.6.1. Target Unresolved Clinical Workflow Problems
13.6.2. Build Cybersecurity and Regulatory Capabilities Early
13.6.3. Pursue Pharmaceutical and Health System Partnerships
13.6.4. Focus on Interoperability and Open Integration
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. State and Regional Market Entry Priorities

What this section provides: This section converts market intelligence into actionable strategy for product development, hospital contracting, home infusion expansion, investment decisions, regional market entry, portfolio positioning, and competitive differentiation.

14. U.S. Infusion Pumps Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Reimbursement Disclaimer
14.7. Company and Competitive Intelligence Disclaimer
14.8. State-Level Market Estimation Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, third-party data conditions, regulatory considerations, and permitted use of market estimates.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Infusion Pumps Market: Market Definition and Scope
TABLE 3: U.S. Infusion Pumps Market: Research Methodology Framework
TABLE 4: U.S. Infusion Pumps Market: Key Assumptions
TABLE 5: U.S. Infusion Pumps Market: Market Ecosystem Overview
TABLE 6: U.S. Infusion Pumps Market: Stakeholder Analysis
TABLE 7: U.S. Infusion Pumps Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Infusion Pumps Market: Analyst Viewpoint Summary
TABLE 9: U.S. Infusion Pumps Market: Market Attractiveness Index
TABLE 10: U.S. Infusion Pumps Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Infusion Pumps Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Infusion Pumps Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Infusion Pumps Market: Drivers; Impact Analysis
TABLE 14: U.S. Infusion Pumps Market: Restraints; Impact Analysis
TABLE 15: U.S. Infusion Pumps Market: Opportunities; Impact Analysis
TABLE 16: U.S. Infusion Pumps Market: Challenges; Impact Analysis
TABLE 17: U.S. Infusion Pumps Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Infusion Pumps Market: Infusion Workflow Economics Matrix
TABLE 19: U.S. Infusion Pumps Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Infusion Pumps Market: PESTEL Analysis
TABLE 21: U.S. Infusion Pumps Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Infusion Pumps Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Infusion Pumps Market: Value Chain Analysis
TABLE 24: U.S. Infusion Pumps Market: Supply Chain Analysis
TABLE 25: U.S. Infusion Pumps Market: Digitalization and Connected Medication Delivery Impact
TABLE 26: U.S. Infusion Pumps Market: Application & Innovation Landscape
TABLE 27: U.S. Infusion Pumps Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Infusion Pumps Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Infusion Pumps Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Infusion Pumps Market: Government Initiatives and Medication-Safety Programs
TABLE 31: U.S. Infusion Pumps Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Infusion Pumps Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Infusion Pumps Market: Product Type Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Type
TABLE 35: U.S. Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 36: U.S. Infusion Pumps Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 37: U.S. Infusion Pumps Market: Large-Volume and Volumetric Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Infusion Pumps Market: Syringe Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Infusion Pumps Market: Insulin Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Infusion Pumps Market: Ambulatory Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Infusion Pumps Market: Patient-Controlled Analgesia Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Infusion Pumps Market: Enteral Feeding Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Infusion Pumps Market: Elastomeric and Disposable Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Infusion Pumps Market: Implantable Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Infusion Pumps Market: On-Body and Specialty Drug-Delivery Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Infusion Pumps Market: Application Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Application
TABLE 48: U.S. Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 49: U.S. Infusion Pumps Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 50: U.S. Infusion Pumps Market: Diabetes Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Infusion Pumps Market: Oncology and Hematology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Infusion Pumps Market: Critical Care and Emergency Medicine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Infusion Pumps Market: Surgery, Anesthesia, and Postoperative Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Infusion Pumps Market: Pain Management and Palliative Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Infusion Pumps Market: Gastroenterology and Clinical Nutrition Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Infusion Pumps Market: Infectious Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Infusion Pumps Market: Immunology, Neurology, and Other Specialty Therapies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Infusion Pumps Market: End User Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by End User
TABLE 60: U.S. Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 61: U.S. Infusion Pumps Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 62: U.S. Infusion Pumps Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Infusion Pumps Market: Ambulatory Infusion Centers and Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Infusion Pumps Market: Oncology and Hematology Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Infusion Pumps Market: Home Infusion Providers and Specialty Pharmacies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Infusion Pumps Market: Diabetes Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Infusion Pumps Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Infusion Pumps Market: Long-Term Care and Skilled Nursing Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Infusion Pumps Market: Homecare Patients and Individual Users Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Infusion Pumps Market: Research, Military, and Other Healthcare Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Infusion Pumps Market: Technology and Delivery Modality Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by Technology and Delivery Modality
TABLE 73: U.S. Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 74: U.S. Infusion Pumps Market: Segment Share Analysis, by Technology and Delivery Modality, 2025 & 2035 (%)
TABLE 75: U.S. Infusion Pumps Market: Smart and Connected Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Infusion Pumps Market: Traditional Programmable Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Infusion Pumps Market: Wearable and Patch-Based Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Infusion Pumps Market: Ambulatory Electronic Infusion Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Infusion Pumps Market: Disposable and Elastomeric Delivery Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Infusion Pumps Market: Implantable Infusion Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Infusion Pumps Market: Software-Enabled and Analytics-Based Infusion Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Infusion Pumps Market: Procurement Channel Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 84: U.S. Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 85: U.S. Infusion Pumps Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 86: U.S. Infusion Pumps Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Infusion Pumps Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Infusion Pumps Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: U.S. Infusion Pumps Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Infusion Pumps Market: Specialty Pharmacy and Home Infusion Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: U.S. Infusion Pumps Market: Retail Pharmacy and Pharmacy Benefit Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: U.S. Infusion Pumps Market: Online and Direct-to-Patient Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: U.S. Infusion Pumps Market: Regional Snapshot, 2025
TABLE 94: Segment Dashboard; Definition and Scope, by Region
TABLE 95: U.S. Infusion Pumps Market, by Region, 2021–2035 (US$ Billion)
TABLE 96: U.S. Infusion Pumps Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 97: West Region U.S. Infusion Pumps Market: Regional Overview and Trends
TABLE 98: West Region U.S. Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 99: West Region U.S. Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: California Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 106: California Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: California Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: California Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 109: California Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Washington Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 111: Washington Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Washington Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Washington Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 114: Washington Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Arizona Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 116: Arizona Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Arizona Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Arizona Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 119: Arizona Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Colorado Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 121: Colorado Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Colorado Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Colorado Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 124: Colorado Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: Oregon Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 126: Oregon Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: Oregon Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: Oregon Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 129: Oregon Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Utah Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 131: Utah Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Utah Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Utah Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 134: Utah Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Nevada Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 136: Nevada Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Nevada Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Nevada Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 139: Nevada Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: New Mexico Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 141: New Mexico Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: New Mexico Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: New Mexico Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 144: New Mexico Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Idaho Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 146: Idaho Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Idaho Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Idaho Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 149: Idaho Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Montana Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 151: Montana Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Montana Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Montana Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 154: Montana Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Wyoming Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 156: Wyoming Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 157: Wyoming Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Wyoming Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 159: Wyoming Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 160: Alaska Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 161: Alaska Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 162: Alaska Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 163: Alaska Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 164: Alaska Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 165: Hawaii Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 166: Hawaii Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 167: Hawaii Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 168: Hawaii Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 169: Hawaii Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Infusion Pumps Market: Regional Overview and Trends
TABLE 171: Northeast Region U.S. Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 172: Northeast Region U.S. Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 173: Northeast Region U.S. Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 174: Northeast Region U.S. Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: Northeast Region U.S. Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: Northeast Region U.S. Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 177: Northeast Region U.S. Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: New York Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 179: New York Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: New York Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: New York Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 182: New York Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Massachusetts Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 184: Massachusetts Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Massachusetts Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Massachusetts Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 187: Massachusetts Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: New Jersey Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 189: New Jersey Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: New Jersey Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: New Jersey Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 192: New Jersey Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Pennsylvania Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 194: Pennsylvania Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Pennsylvania Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Pennsylvania Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 197: Pennsylvania Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: Connecticut Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 199: Connecticut Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: Connecticut Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: Connecticut Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 202: Connecticut Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Maine Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 204: Maine Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Maine Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Maine Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 207: Maine Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Vermont Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 209: Vermont Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Vermont Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Vermont Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 212: Vermont Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: New Hampshire Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 214: New Hampshire Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 215: New Hampshire Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 216: New Hampshire Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 217: New Hampshire Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 218: Rhode Island Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 219: Rhode Island Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 220: Rhode Island Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 221: Rhode Island Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 222: Rhode Island Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 223: Delaware Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 224: Delaware Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 225: Delaware Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 226: Delaware Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 227: Delaware Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Infusion Pumps Market: Regional Overview and Trends
TABLE 229: South Region U.S. Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 230: South Region U.S. Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 231: South Region U.S. Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 232: South Region U.S. Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: South Region U.S. Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: South Region U.S. Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 235: South Region U.S. Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: Texas Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 237: Texas Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: Texas Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: Texas Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 240: Texas Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Florida Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 242: Florida Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Florida Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: Florida Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 245: Florida Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: Georgia Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 247: Georgia Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: Georgia Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: Georgia Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 250: Georgia Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: North Carolina Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 252: North Carolina Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: North Carolina Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: North Carolina Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 255: North Carolina Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Tennessee Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 257: Tennessee Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Tennessee Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Tennessee Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 260: Tennessee Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: South Carolina Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 262: South Carolina Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: South Carolina Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: South Carolina Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 265: South Carolina Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Alabama Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 267: Alabama Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Alabama Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Alabama Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 270: Alabama Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Mississippi Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 272: Mississippi Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Mississippi Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Mississippi Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 275: Mississippi Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Louisiana Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 277: Louisiana Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Louisiana Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Louisiana Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 280: Louisiana Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Arkansas Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 282: Arkansas Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Arkansas Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Arkansas Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 285: Arkansas Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Kentucky Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 287: Kentucky Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Kentucky Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Kentucky Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 290: Kentucky Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: Oklahoma Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 292: Oklahoma Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: Oklahoma Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: Oklahoma Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 295: Oklahoma Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Virginia Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 297: Virginia Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 298: Virginia Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 299: Virginia Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 300: Virginia Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 301: Maryland Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 302: Maryland Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 303: Maryland Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 304: Maryland Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 305: Maryland Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 306: West Virginia Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 307: West Virginia Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 308: West Virginia Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 309: West Virginia Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 310: West Virginia Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Infusion Pumps Market: Regional Overview and Trends
TABLE 312: Midwest Region U.S. Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 313: Midwest Region U.S. Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 314: Midwest Region U.S. Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 315: Midwest Region U.S. Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Midwest Region U.S. Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Midwest Region U.S. Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 318: Midwest Region U.S. Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Illinois Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 320: Illinois Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Illinois Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Illinois Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 323: Illinois Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Ohio Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 325: Ohio Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Ohio Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Ohio Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 328: Ohio Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Michigan Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 330: Michigan Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Michigan Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Michigan Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 333: Michigan Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Minnesota Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 335: Minnesota Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Minnesota Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Minnesota Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 338: Minnesota Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Indiana Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 340: Indiana Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Indiana Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Indiana Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 343: Indiana Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Wisconsin Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 345: Wisconsin Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Wisconsin Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Wisconsin Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 348: Wisconsin Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Missouri Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 350: Missouri Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Missouri Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Missouri Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 353: Missouri Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: Iowa Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 355: Iowa Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: Iowa Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: Iowa Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 358: Iowa Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: Kansas Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 360: Kansas Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: Kansas Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: Kansas Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 363: Kansas Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: Nebraska Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 365: Nebraska Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 366: Nebraska Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 367: Nebraska Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 368: Nebraska Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 369: North Dakota Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 370: North Dakota Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 371: North Dakota Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 372: North Dakota Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 373: North Dakota Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 374: South Dakota Infusion Pumps Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 375: South Dakota Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 376: South Dakota Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 377: South Dakota Infusion Pumps Market, by Technology and Delivery Modality, 2021–2035 (US$ Billion)
TABLE 378: South Dakota Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 379: U.S. Infusion Pumps Market: Competitive Landscape Snapshot, 2025
TABLE 380: U.S. Infusion Pumps Market: Institutional Infusion Pump Market Share Analysis, 2025
TABLE 381: U.S. Infusion Pumps Market: Insulin Pump Market Share Analysis, 2025
TABLE 382: U.S. Infusion Pumps Market: Ambulatory and Home Infusion Pump Market Share Analysis, 2025
TABLE 383: U.S. Infusion Pumps Market: Enteral, Elastomeric, and Specialty Pump Market Share Analysis, 2025
TABLE 384: U.S. Infusion Pumps Market: Company Positioning Matrix
TABLE 385: U.S. Infusion Pumps Market: Product Portfolio Benchmarking of Key Players
TABLE 386: U.S. Infusion Pumps Market: Installed Base and Recurring Consumable Revenue Benchmarking
TABLE 387: U.S. Infusion Pumps Market: Interoperability, Software, and Cybersecurity Benchmarking
TABLE 388: U.S. Infusion Pumps Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 389: Baxter International: Company Profile
TABLE 390: Becton, Dickinson and Company: Company Profile
TABLE 391: ICU Medical: Company Profile
TABLE 392: B. Braun Medical: Company Profile
TABLE 393: Fresenius Kabi: Company Profile
TABLE 394: Medtronic: Company Profile
TABLE 395: Insulet Corporation: Company Profile
TABLE 396: Tandem Diabetes Care: Company Profile
TABLE 397: Sequel Med Tech: Company Profile
TABLE 398: Ypsomed: Company Profile
TABLE 399: SOOIL Development: Company Profile
TABLE 400: Terumo Corporation: Company Profile
TABLE 401: Nipro Corporation: Company Profile
TABLE 402: Moog Medical: Company Profile
TABLE 403: Eitan Medical: Company Profile
TABLE 404: KORU Medical Systems: Company Profile
TABLE 405: Avanos Medical: Company Profile
TABLE 406: CODAN Companies: Company Profile
TABLE 407: Zyno Medical: Company Profile
TABLE 408: InfuSystem Holdings: Company Profile
TABLE 409: Enable Injections: Company Profile
TABLE 410: West Pharmaceutical Services: Company Profile
TABLE 411: Gerresheimer: Company Profile
TABLE 412: United Therapeutics: Company Profile
TABLE 413: Cardinal Health: Company Profile
TABLE 414: U.S. Infusion Pumps Market: Future Market Scenario Analysis, 2026–2035
TABLE 415: U.S. Infusion Pumps Market: Disruptive Technologies Impact Matrix
TABLE 416: U.S. Infusion Pumps Market: Emerging Business Trends
TABLE 417: U.S. Infusion Pumps Market: Business Opportunities for Startups and Existing Players
TABLE 418: U.S. Infusion Pumps Market: Investment Prioritization Matrix
TABLE 419: U.S. Infusion Pumps Market: Market Consolidation and Partnership Outlook
TABLE 420: U.S. Infusion Pumps Market: Long-Term Competitive Structure
TABLE 421: U.S. Infusion Pumps Market: Strategic Recommendations for Infusion Pump Manufacturers
TABLE 422: U.S. Infusion Pumps Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 423: U.S. Infusion Pumps Market: Strategic Recommendations for Home Infusion Providers and Specialty Pharmacies
TABLE 424: U.S. Infusion Pumps Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 425: U.S. Infusion Pumps Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 426: U.S. Infusion Pumps Market: Strategic Recommendations for New Entrants and Startups
TABLE 427: U.S. Infusion Pumps Market: Go-to-Market Strategy Considerations
TABLE 428: U.S. Infusion Pumps Market: Product Positioning and Portfolio Expansion Guidance
TABLE 429: U.S. Infusion Pumps Market: State and Regional Market Entry Priorities
TABLE 430: U.S. Infusion Pumps Market: Scope Limitation
TABLE 431: U.S. Infusion Pumps Market: Data Use Limitation
TABLE 432: U.S. Infusion Pumps Market: Forecasting Limitation
TABLE 433: U.S. Infusion Pumps Market: Legal Disclaimer
TABLE 434: U.S. Infusion Pumps Market: Third-Party Data Disclaimer
TABLE 435: U.S. Infusion Pumps Market: Regulatory and Reimbursement Disclaimer
TABLE 436: U.S. Infusion Pumps Market: Company and Competitive Intelligence Disclaimer
TABLE 437: U.S. Infusion Pumps Market: State-Level Market Estimation Disclaimer

List of Figures

FIGURE 1: U.S. Infusion Pumps Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Infusion Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Infusion Pumps Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Infusion Pumps Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Infusion Pumps Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Large-Volume and Volumetric Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Syringe Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Insulin Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Ambulatory Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Patient-Controlled Analgesia Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Enteral Feeding Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Elastomeric and Disposable Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Implantable Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: On-Body and Specialty Drug-Delivery Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Diabetes Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Oncology and Hematology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Critical Care and Emergency Medicine Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Surgery, Anesthesia, and Postoperative Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Pain Management and Palliative Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Gastroenterology and Clinical Nutrition Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Infectious Disease Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Immunology, Neurology, and Other Specialty Therapies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Ambulatory Infusion Centers and Hospital Outpatient Departments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Oncology and Hematology Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Home Infusion Providers and Specialty Pharmacies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Diabetes Clinics and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Long-Term Care and Skilled Nursing Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Homecare Patients and Individual Users Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Research, Military, and Other Healthcare Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Technology and Delivery Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Technology and Delivery Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Smart and Connected Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Traditional Programmable Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Wearable and Patch-Based Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Ambulatory Electronic Infusion Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Disposable and Elastomeric Delivery Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Implantable Infusion Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Software-Enabled and Analytics-Based Infusion Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 57: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Specialty Pharmacy and Home Infusion Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Retail Pharmacy and Pharmacy Benefit Channels Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Online and Direct-to-Patient Channels Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 66: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: West Region U.S. Infusion Pumps Market Share and Leading Players, 2025
FIGURE 68: West Region Market Share Analysis by State, 2025
FIGURE 69: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: California Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Washington Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Arizona Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Colorado Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Oregon Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Utah Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Nevada Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Mexico Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Idaho Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Montana Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Wyoming Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Alaska Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Hawaii Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Northeast Region U.S. Infusion Pumps Market Share and Leading Players, 2025
FIGURE 84: Northeast Region Market Share Analysis by State, 2025
FIGURE 85: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: New York Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Massachusetts Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: New Jersey Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Pennsylvania Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Connecticut Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Maine Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Vermont Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: New Hampshire Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Rhode Island Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Delaware Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: South Region U.S. Infusion Pumps Market Share and Leading Players, 2025
FIGURE 97: South Region Market Share Analysis by State, 2025
FIGURE 98: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Texas Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Florida Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Georgia Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: North Carolina Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Tennessee Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: South Carolina Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Alabama Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Mississippi Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Louisiana Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Arkansas Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Kentucky Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Oklahoma Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Virginia Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Maryland Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: West Virginia Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Midwest Region U.S. Infusion Pumps Market Share and Leading Players, 2025
FIGURE 115: Midwest Region Market Share Analysis by State, 2025
FIGURE 116: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Illinois Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Ohio Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Michigan Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Minnesota Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Indiana Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Wisconsin Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Missouri Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Iowa Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 125: Kansas Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 126: Nebraska Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 127: North Dakota Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 128: South Dakota Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 129: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 130: Company Positioning Matrix
FIGURE 131: Key Player Product Portfolio Benchmarking
FIGURE 132: Interoperability, Software, and Cybersecurity Benchmarking
FIGURE 133: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 134: Infusion Pump Innovation Roadmap
FIGURE 135: Smart Pump Interoperability Adoption Roadmap
FIGURE 136: Automated Insulin Delivery Opportunity Map
FIGURE 137: Home Infusion Growth Roadmap
FIGURE 138: Future Market Scenario Analysis, 2026–2035
FIGURE 139: Disruptive Technologies Impact Matrix
FIGURE 140: Emerging Business Trends Matrix
FIGURE 141: Investment Prioritization Matrix
FIGURE 142: Strategic Growth Roadmap for U.S. Infusion Pump Companies
FIGURE 143: Go-to-Market Strategy Framework
FIGURE 144: Product Positioning and Portfolio Expansion Framework
FIGURE 145: Report Scope and Disclaimer Framework